Time-course and localization of transferrin receptor expression in the substantia nigra of 6-hydroxydopamine-induced parkinsonian rats

Neuroscience

Volumn 91, Issue 2, 1999, Pages 579-585

  He, Y ^a   Lee, T ^a   Leong, S K ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

6 hydroxydopamine; Iron; Parkinson's disease; Rat; Substantia nigra; Transferrin receptor

Indexed keywords

OXIDOPAMINE; TRANSFERRIN; TRANSFERRIN RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; CELL DEATH; COMPUTER ANALYSIS; DOPAMINERGIC TRANSMISSION; IMAGE ANALYSIS; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN ANALYSIS; RAT; SUBSTANTIA NIGRA;

ANIMALS; FUNCTIONAL LATERALITY; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; MALE; OXIDOPAMINE; PARKINSON DISEASE, SECONDARY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, TRANSFERRIN; SUBSTANTIA NIGRA; TIME FACTORS; TYROSINE 3-MONOOXYGENASE;

EID: 0032909585     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(98)00669-1     Document Type: Article

References (31)

1. Aisen P. Entry of iron into cells: a new role for the transferrin receptor in modulating iron release from transferrin. Ann. Neurol. 32:1992;S62-S68.
2. Ben-Shachar D., Eshel G., Finberg J.P.M., Youdim M.B.H. The iron chelator desferrioxamine (desferal) retards 6-hydroxydopamine-induced degeneration of nigrostriatal dopamine neurons. J. Neurochem. 56:1991;1441-1444.
3. Ben-Shachar D., Youdim M.B.H. Intranigral iron injection induces behavioral and biochemical "Parkinsonism" in rats. J. Neurochem. 57:1991;2133-2135.
4. Burke R.E., Macaya A., DeVivo D., Kenyon N., Janec E.M. Neonatal hypoxic-ischemic or excitotoxic striatal injury results in a decreased adult number of substantia nigra neurons. Neuroscience. 50:1992;559-569.
5. Dexter D.T., Wells F.R., Lees A.J., Agid Y., Jenner P., Marsden C.D. Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease. J. Neurochem. 52:1989;1830-1836.
6. 125I-ferrotransferrin binding sites in the mesencephalon of control subjects and patients with Parkinson's disease. J. Neurochem. 60:1993;2338-2341.
7. Faucheux B.A., Nillesse N., Damier P., Spik G., Mouatt-Prigent A., Pierce A., Leveugle B., Kubis N., Hauw J.J., Agid Y. Expression of lactoferrin receptors is increased in the mesencephalon of patients with Parkinson disease. Proc. natn. Acad. Sci. U.S.A. 92:1995;9603-9607.
8. Gelman B.B. Iron in CNS disease. J. Neuropath. exp. Neurol. 54:1995;477-486.
9. Gerlach M., Ben-Shachar D., Riederer P., Youdim M.B.H. Altered brain metabolism of iron as a cause of neurodegenerative diseases? J. Neurochem. 63:1994;793-807.
10. Giometto B., Bozza F., Argenitiero V., Gallo P., Pagni S., Piccinno M.G., Tavolato B. Transferrin receptors in rat central nervous system. An immunocytochemical study. J. neurol. Sci. 98:1990;81-90.
11. Good P.F., Perl D.P., Bierer L.M., Schmeidler J. Selective accumulation of aluminium and iron in the neurofibrillary tangles of Alzheimer's disease: a laser microprobe (LAMMA) study. Ann. Neurol. 31:1992;286-292.
12. Graham D.G., Tiffany S.M., Bell W.R., Gutknecht W.F. Autooxidation versus covalent binding quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine and related compounds towards Cl 300 neuroblastoma cells in vitro. Molec. Pharmac. 14:1978;644-653.
13. Gunshin H., Mackenzie B., Berger U.V., Gunshin Y., Romero M.F., Boron W.F., Nussberger S., Gollan J.L., Hediger M.A. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature. 388:1997;482-488.
14. Halliwell B. Reactive oxygen species and the central nervous system. J. Neurochem. 59:1992;1609-1623.
15. He Y., Thong P.S.P., Lee T., Leong S.K., Shi C.Y., Wong P.T.H., Yuan S.Y., Watt F. Increased iron in the substantia nigra of 6-OHDA induced parkinsonian rats: a nuclear microscopy study. Brain Res. 735:1996;149-153.
16. Hill J.M., Ruff M.R., Weber R.J., Pert C.B. Transferrin receptors in rat brain: neuropeptide-like pattern and relationship to iron distribution. Proc. natn. Acad. Sci. U.S.A. 82:1985;4553-4557.
17. Jefferies W.A., Brandon M.R., Hunt S.V., Williams A.F., Gatter K.C., Mason D.Y. Transferrin receptor on endothelium of brain capillaries. Nature. 312:1984;162-163.
18. Jenner P. Oxidative stress as a cause of Parkinson's disease. Acta neurol. scand., Suppl. 136:1991;6-15.
19. Kalaria R.N., Sromek S.M., Grahovac I., Harik S.I. Transferrin receptors of rat and human brain and cerebral microvessels and their status in Alzheimer's disease. Brain Res. 585:1992;87-93.
20. Kaur C., Ling E.A. Transient expression of transferrin receptors and localisation of iron in amoeboid microglia in postnatal rats. J. Anat. 186:1995;165-173.
21. Malorni W., Losi F., Santini M.T., Testa U. Menadione-induced oxidative stress leads to a rapid down-modulation of transferrin receptor recycling. J. Cell Sci. 106:1993;309-318.
22. Mash D.C., Pablo J., Flynn D.D., Efange S.M.N., Weiner W.J. Characterization and distribution of transferrin receptors in the rat brain. J. Neurochem. 55:1990;1972-1979.
23. Mash D.C., Pablo J., Buck B.E., Sanchez-Ramos J., Weiner W.J. Distribution and number of transferrin receptors in Parkinson's disease and in MPTP-treated mice. Expl Neurol. 114:1991;73-81.
24. Monteiro H.P., Winterbourn C.C. 6-Hydroxydopamine releases iron from ferritin and promotes ferritin-dependent lipid peroxidation. Biochem. Pharmac. 38:1989;4177-4182.
25. Morris C.M., Candy J.M., Keith A.B., Oakley A.E., Taylor G.A., Pullen R.G.L., Bloxham C.A., Gocht A., Edwardson J.A. Brain iron homeostasis. J. inorg. Biochem. 47:1992;257-265.
26. Morris C.M., Keith A.B., Edwardson J.A., Pullen R.G.L. Uptake and distribution of iron and transferrin in the adult rat brain. J. Neurochem. 59:1992;300-306.
27. Morris C.M., Candy J.M., Omar S., Bloxham C.A., Edwardson J.A. Transferrin receptors in the parkinsonian midbrain. Neuropath. appl. Neurobiol. 20:1994;468-472.
28. Muthane U., Ramsay K.A., Jiang H., Jachson-Lewis V., Donaldson D., Fernando S., Ferreira M., Przedborski S. Differences in nigral neuron number and sensitivity to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57/b1 and CD-1 mice. Expl Neurol. 126:1994;195-204.
29. Oestreicher E., Sengstock G.J., Riederer P., Olanow C.W., Dunn A.J., Arendash G.W. Degeneration of nigrostriatal dopaminergic neurons increases iron within the substantia nigra: a histochemical and neurochemical study. Brain Res. 660:1994;8-18.
30. Paxinos G. and Watson C. (1986) The Rat Brain in Stereotaxic Coordinates. Academic, New York.
31. Sofic E., Paulus W., Jellinger K., Riederer P., Youdim M.B.H. Selective increase of iron in substantia nigra zona compacta of parkinsonian brains. J. Neurochem. 56:1991;978-982.